Celecoxib-Induced Self-Assembly of Smart Albumin-Doxorubicin Conjugate for Enhanced Cancer Therapy

ACS Applied Materials & Interfaces
Leilei ShiXinyuan Zhu

Abstract

Recent years have witnessed the great contributions that drug combination therapy has made for enhanced cancer therapy. However, because of the complicated pharmacokinetics of combined drug formulations, the majority of combination strategies show severe adverse effects at high dosage and poor biodistribution in vivo. To overcome these deficiencies and achieve enhanced cancer therapy, we put forward a method to construct a smart albumin-based nanoplatform, denoted as K237-HSA-DC, for codelivery of cyclooxygenase-2 (COX-2) inhibitor (celecoxib) and chemotherapeutic agent (doxorubicin, DOX). Both in vitro and in vivo studies indicate that K237-HSA-DC exhibits the best therapeutic efficacy on tumor cells compared with all the other formulations. Moreover, K237-HSA-DC shows fewer side effects on normal organs in contrast to other formulations. To understand the reasons behind the improved drug efficacy in depth, we performed a cell metabonomics-based mechanism study and found that celecoxib could enhance the inhibitory effect of DOX on the transport of glucose into cells and then lead to subsequent significant energy metabolism inhibition. Considering the above-mentioned advantages of K237-HSA-DC, we believe the smart albumin-based...Continue Reading

References

Jan 5, 1996·Biochimica Et Biophysica Acta·H R Herschman
Jan 1, 1996·Fundamental & Clinical Pharmacology·M Pairet, G Engelhardt
Dec 22, 2000·BMJ : British Medical Journal·W Sneader
Nov 13, 2001·British Journal of Pharmacology·Y S Bakhle
Mar 6, 2003·Cancer Letters·Tajamul HussainHasan Mukhtar
Aug 4, 2006·Cancer Research·Jacob G BundyKevin M Brindle
Oct 13, 2006·Journal of the American Chemical Society·Haimei ChenThomas V O'Halloran
Nov 14, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jens van WijngaardenClemens W G M Löwik
Mar 27, 2007·Nature Reviews. Cancer·Angelo M De MarzoWilliam G Nelson
Jul 31, 2007·BJU International·Florian M E WagenlehnerWolfgang Weidner
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Benjamin J BlaiseLyndon Emsley
Jun 28, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Felix Kratz
Jul 22, 2010·Angewandte Chemie·Katrin KnopUlrich S Schubert
Feb 25, 2011·Cancer Letters·Verena Jendrossek
Apr 22, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Emanuela Ricciotti, Garret A FitzGerald
Nov 13, 2012·Annual Review of Pharmacology and Toxicology·Urs A MeyerMatthias Schwab
Jan 24, 2014·Angewandte Chemie·Rakesh K PathakShanta Dhar
Apr 30, 2014·Chemical Communications : Chem Comm·Qinqin ChengYangzhong Liu
Jun 7, 2014·Journal of the American Chemical Society·Yao-Rong ZhengStephen J Lippard
Aug 1, 2014·Journal of the American Chemical Society·Ping HuangDeyue Yan
Jun 19, 2015·Journal of the American Chemical Society·Rakesh K Pathak, Shanta Dhar

❮ Previous
Next ❯

Citations

Oct 21, 2018·Journal of Cellular Physiology·Nasser Hashemi GoradelKeywan Mortezaee
Dec 5, 2019·Advanced Healthcare Materials·Lixia GuoLiheng Feng
Jan 31, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Kaicheng Liang, Hangrong Chen
Aug 22, 2020·Expert Opinion on Drug Delivery·Islam A Hassanin, Ahmed O Elzoghby
Oct 2, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Wenkun HanWenjing Tian
Jun 15, 2019·Biomolecules·Alessandro ParodiAndrey A Zamyatnin
Dec 2, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mei ZhangNorbert Radacsi
Oct 13, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sena KaraosmanogluXianfeng Chen
Apr 10, 2021·Biomaterials·Yachao ZhangShuangying Gui
Jun 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuangshuang LiShuwen Yu
Jun 5, 2018·ACS Applied Materials & Interfaces·Yincheng ChangXi Zhang
Dec 7, 2018·ACS Applied Materials & Interfaces·Wei ZhangZhigang Xie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.